← Earnings Calls
BXP FY2025 Q4 Improving

BXP, Inc. earnings call

Jan 28, 2026 · 10:00 ET Doug LindyHelen HahnMike LaBelle earningscall_biz
Buzzberg read

Occupancy target of 89% by end of 2026 remains on track

BXP reported strong leasing activity and a solid start to its disposition program, providing 2026 guidance for a return to FFO growth driven by occupancy gains and development deliveries. Management emphasized the strength of the premier workplace segment and robust AI-driven demand in key markets like San Francisco and New York, while tempering expectations with the dilutive impact of asset sales and costs related to repositioning land for residential development. Full year 2025 FFO per share was $6.85, with Q4 FFO of $1.76 missing guidance by $0.05 due to higher G&A and credit reserves.

Buzzberg read Occupancy target of 89% by end of 2026 remains on track BXP reported strong leasing activity and a solid start to its disposition program, providing 2026 guidance for a return to FFO growth driven by occupancy gains and development deliveries. Management emphasized the strength of the premier workplace segment and robust AI-driven demand in key markets like San Francisco and New York, while tempering expectations with the dilutive impact of asset sales and costs related to repositioning land for residential development. Full year 2025 FFO per share was $6.85, with Q4 FFO of $1.76 missing guidance by $0.05 due to higher G&A and credit reserves. Read full analysisCollapse analysis

BXP reported strong leasing activity and a solid start to its disposition program, providing 2026 guidance for a return to FFO growth driven by occupancy gains and development deliveries. Management emphasized the strength of the premier workplace segment and robust AI-driven demand in key markets like San Francisco and New York, while tempering expectations with the dilutive impact of asset sales and costs related to repositioning land for residential development. Full year 2025 FFO per share was $6.85, with Q4 FFO of $1.76 missing guidance by $0.05 due to higher G&A and credit reserves.

  • 2026 FFO guidance of $6.88-$7.04 per share implies a return to growth, driven by occupancy gains, development deliveries (like 290 Binney Street), and lower interest expense.
  • BXP is aggressively selling assets ($1.25B closed/underway) and re-entitling land for residential development, creating a near-term earnings drag but positioning for higher-value future use.
  • Management sees robust demand, particularly in the premier workplace segment, with AI companies driving absorption in San Francisco and New York.
Revenue$0.8771BReported
EPS$1.76Reported
Gross margin60.23%Reported
Free cash flow$0.2671BReported
6 grounded callouts

What matters now

The highest-signal changes from the call.

01
Guidance

Occupancy target of 89% by end of 2026 remains on track

02
AI

AI demand accelerating in Bay Area and New York

03
Demand

Premier workplace segment outperforming broader office market

Show 3 more callouts
04
Capital Allocation

Asset sales progress ahead of plan, $1.25B closed or underway

05
Development

343 Madison to be recapitalized in 2026 with partner

06
Guidance

2026 FFO guidance midpoint implies EPS growth

Reported period

Actuals

MetricReportedChange
Revenue$0.8771BReported
EPS$1.76Reported
Gross margin60.23%Reported
Free cash flow$0.2671BReported
Capex$0.1406BReported
Net income$0.2485BReported
Forward-looking

Forward guidance

MetricPeriodRangeMidpointStatus
EPSFY2026$6.88–$7.04In line with consensus$6.96Initiated
Operating marginSAME_PROPERTY_NOIFY20261.25%–2.25%1.75%Initiated
Operating marginSAME_PROPERTY_CASH_NOIFY20260%–0.5%0.25%Initiated
AI, capex & demand read

Management read

Tone

Upbeat

Management repeatedly emphasized strong leasing, occupancy gains, and progress on asset sales, while expressing confidence in future growth.

AI

Management AI read

Management sees AI as a net positive for BXP, citing accelerating demand from AI companies in the Bay Area and New York, and notes that AI job displacement is more likely in support functions not occupying premier workplaces.

Capex

Investment and capacity

BXP is increasing development capex for new premier workplace office projects and multifamily residential, funded through asset sales and partnerships, with expectations of over 8% cash yields. Leasing capital per square foot was an outlier high this quarter, but management expects it to normalize around $100.

all 1 named companies below

Companiesreturns since call

Customers

Customers

AstraZeneca is the anchor tenant for BXP's largest 2026 development delivery, providing stable, contracted NOI growth.

Evidence
“The most meaningful development that will impact 2026 is our 573,000 square foot, 290 Benny Street life science project in Cambridge that is 100% leased to AstraZeneca.”
Mike LaBelle
External signals

Supply-chain alpha · 3returns since call

A1

BXP is aggressively converting suburban office land and buildings into residential entitlements, with over 3,500 residential units in the pipeline, indicating a structural shift away from suburban office supply.

Evidence
“To date, we have sold or are in the process of selling land to a corporate user, a municipal user, a light manufacturing developer, a utility, and most importantly, developers for residential use, both apartments and for sale townhomes.”
A2

AI demand is creating a bifurcation in the office market: strong, rapid absorption of lab and data-center adjacent office space in the Bay Area and NYC, but this has not yet pulled through to traditional professional services tenants in high-rise assets.

Evidence
“While the AI demand has not translated into commensurate growth in ancillary professional service tenants and high-rise assets in the markets, overall non-AI client activity is also improving.”
A3

BXP's strategy of taking properties out of service for residential redevelopment is a meaningful drag on near-term FFO, but positions land for higher-value uses.

Evidence
“The reduction in NOI from these buildings in 2026 is $13 million or 7 cents per share.”
Methodology & coverage

Management-only analysis. All 1 validated company mentions are shown. Reported actuals and forward guidance are kept separate. Public evidence is limited to eight short attributed quotes. AI-generated analysis can be incomplete or wrong; verify important claims against the original source.